Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 19:13:55 GMT 2023
by
admin
on
Sat Dec 16 19:13:55 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | AUTOLOGOUS HUMAN |
| Source Materials State | LIVE GENETICALLY MODIFIED |
| Source Materials Parent | |
| Part | BLOOD |
| Fraction Name | CD4/CD8 T cells |
| Record UNII |
WD9M7WQ9SY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
WD9M7WQ9SY
Created by
admin on Sat Dec 16 19:13:55 GMT 2023 , Edited by admin on Sat Dec 16 19:13:55 GMT 2023
|
PRIMARY | |||
|
12821
Created by
admin on Sat Dec 16 19:13:55 GMT 2023 , Edited by admin on Sat Dec 16 19:13:55 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->CYTOTOXIC T-CELL |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
A preparation of autologous T lymphocytes that are genetically engineered with a T-cell Antigen Coupler (TAC), comprising of a domain that targets the tumor-associated antigen (TAA) human epidermal growth factor receptor 2 (HER2) and another domain that binds to the endogenous T-cell receptor (TCR), with potential immunostimulating and antineoplastic activities.
|